CHG-2024-0113

Analytical Method Change for Upadacitimab. Manufacturing Process Change for Upadacitimab — major revision. Impacts 3 markets and 2 variations.

Change Number
CHG-2024-0113
Type
Analytical Method Change
Product
Upadacitimab
Status
Active
Owner
Priya Sharma
Initiated
2022-11-10
Description

Manufacturing Process Change for Upadacitimab — major revision

Impacted Markets (3)
AU — AustraliaES — SpainSA — Saudi Arabia
Impacted Modules
2.3.P3.2.S4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved